For this purpose, we blocked GIPR signaling after its overexpression in two RB cell lines with a specific inhibitor (MK0893) and treated the cells with recombinant TFF1 (rTFF1) alone or in combination with MK0893 and analyzed effects on cell viability, proliferation, and apoptosis. The gene discussed is GIPR; the disease is retinoblastoma.